220 related articles for article (PubMed ID: 19540323)
1. The effect of temperature and moisture on the amorphous-to-crystalline transformation of stavudine.
Strydom S; Liebenberg W; Yu L; de Villiers M
Int J Pharm; 2009 Sep; 379(1):72-81. PubMed ID: 19540323
[TBL] [Abstract][Full Text] [Related]
2. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
[TBL] [Abstract][Full Text] [Related]
3. Investigating the moisture sorption behavior of amorphous sucrose using a dynamic humidity generating instrument.
Yu X; Kappes SM; Bello-Perez LA; Schmidt SJ
J Food Sci; 2008 Jan; 73(1):E25-35. PubMed ID: 18211350
[TBL] [Abstract][Full Text] [Related]
4. Solid state characterization of the anti-HIV drug TMC114: interconversion of amorphous TMC114, TMC114 ethanolate and hydrate.
Van Gyseghem E; Stokbroekx S; de Armas HN; Dickens J; Vanstockem M; Baert L; Rosier J; Schueller L; Van den Mooter G
Eur J Pharm Sci; 2009 Dec; 38(5):489-97. PubMed ID: 19782132
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical relationships of three solid state forms of stavudine.
Gandhi RB; Bogardus JB; Bugay DE; Perrone RK; Kaplan MA
Int J Pharm; 2000 May; 201(2):221-37. PubMed ID: 10878328
[TBL] [Abstract][Full Text] [Related]
6. Moisture sorption, compressibility and caking of lactose polymorphs.
Listiohadi Y; Hourigan JA; Sleigh RW; Steele RJ
Int J Pharm; 2008 Jul; 359(1-2):123-34. PubMed ID: 18485633
[TBL] [Abstract][Full Text] [Related]
7. Solid state amorphization of pharmaceuticals.
Willart JF; Descamps M
Mol Pharm; 2008; 5(6):905-20. PubMed ID: 18954076
[TBL] [Abstract][Full Text] [Related]
8. Characterization and monitoring of pseudo-polymorphs in manufacturing process by NIR.
Kamada K; Yoshimura S; Murata M; Murata H; Nagai H; Ushio H; Terada K
Int J Pharm; 2009 Feb; 368(1-2):103-8. PubMed ID: 19007870
[TBL] [Abstract][Full Text] [Related]
9. The influence of heterogeneous nucleation on the surface crystallization of guaifenesin from melt extrudates containing Eudragit L10055 or Acryl-EZE.
Bruce CD; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Eur J Pharm Biopharm; 2010 May; 75(1):71-8. PubMed ID: 19995604
[TBL] [Abstract][Full Text] [Related]
10. An investigation into the influence of counterion on the properties of some amorphous organic salts.
Towler CS; Li T; Wikström H; Remick DM; Sanchez-Felix MV; Taylor LS
Mol Pharm; 2008; 5(6):946-55. PubMed ID: 19434850
[TBL] [Abstract][Full Text] [Related]
11. Formation and physical stability of the amorphous phase of ranitidine hydrochloride polymorphs prepared by cryo-milling.
Chieng N; Rades T; Saville D
Eur J Pharm Biopharm; 2008 Mar; 68(3):771-80. PubMed ID: 17945474
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches.
Fakes MG; Vakkalagadda BJ; Qian F; Desikan S; Gandhi RB; Lai C; Hsieh A; Franchini MK; Toale H; Brown J
Int J Pharm; 2009 Mar; 370(1-2):167-74. PubMed ID: 19100319
[TBL] [Abstract][Full Text] [Related]
13. Devitrification of amorphous celecoxib.
Gupta P; Bansal AK
AAPS PharmSciTech; 2005 Sep; 6(2):E223-30. PubMed ID: 16353981
[TBL] [Abstract][Full Text] [Related]
14. Quantifying crystallisation rates of amorphous pharmaceuticals with dynamic mechanical analysis (DMA).
Soutari N; Buanz AB; Gul MO; Tuleu C; Gaisford S
Int J Pharm; 2012 Feb; 423(2):335-40. PubMed ID: 22101291
[TBL] [Abstract][Full Text] [Related]
15. Solid form selection of zwitterionic 5-HT4 receptor agonist.
Kojima T; Sugano K; Onoue S; Murase N; Sato M; Kawabata Y; Mano T
Int J Pharm; 2008 Feb; 350(1-2):35-42. PubMed ID: 17919860
[TBL] [Abstract][Full Text] [Related]
16. Protection of moisture-sensitive drugs with aqueous polymer coatings: importance of coating and curing conditions.
Bley O; Siepmann J; Bodmeier R
Int J Pharm; 2009 Aug; 378(1-2):59-65. PubMed ID: 19477253
[TBL] [Abstract][Full Text] [Related]
17. Modeling Physical Stability of Amorphous Solids Based on Temperature and Moisture Stresses.
Zhu DA; Zografi G; Gao P; Gong Y; Zhang GGZ
J Pharm Sci; 2016 Sep; 105(9):2932-2939. PubMed ID: 27185539
[TBL] [Abstract][Full Text] [Related]
18. Quantitative determination of solid-state forms of a pharmaceutical development compound in drug substance and tablets.
Xie Y; Tao W; Morrison H; Chiu R; Jona J; Fang J; Cauchon N
Int J Pharm; 2008 Oct; 362(1-2):29-36. PubMed ID: 18588963
[TBL] [Abstract][Full Text] [Related]
19. Thermodynamics of water-solid interactions in crystalline and amorphous pharmaceutical materials.
Sacchetti M
J Pharm Sci; 2014 Sep; 103(9):2772-2783. PubMed ID: 24327540
[TBL] [Abstract][Full Text] [Related]
20. [Physical ageing of amorphous polymeric excipients III. The possible consequences of ageing].
Zelkó R; Kiss D
Acta Pharm Hung; 2006; 76(2):105-13. PubMed ID: 17094669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
